Top Abstract Purchase Related
Home
>
Node
>
Subnode

Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression

Sherman, T.L.; McDougle, C.J.; Price, L.H.

Connecticut Medicine 57(9): 587-592

1993

ISSN/ISBN: 0010-6178
PMID: 8252846
Document Number: 406123
The introduction of the selective serotonin reuptake inhibitors (SSRIs) over the past several years has made a major impact on the treatment of depression and other neuropsychiatric disorders. Agents in this heterogeneous group of compounds are generally better tolerated and less toxic than the tricyclic antidepressants (TCAs), which they have in many respects superseded. This review summarizes available data on paroxetine, the newest SSRI to receive approval for the treatment of depression.

Document emailed within 1 workday
Secure & encrypted payments

Nemeroff, C.B. 1993: Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression Journal of Clinical Psychopharmacology 13(6 Suppl 2): 10s-17s
Akagawa, Y.; Masuda, Y.; Maruyama, A.; Shimizu, T.; Hishikawa, Y. 1999: Effects of repeated selective serotonin reuptake inhibitor paroxetine treatments on mouse forced swimming Methods and Findings in Experimental and Clinical Pharmacology 21(9): 599-601
Hu, X.Henry.; Bull, S.A.; Hunkeler, E.M.; Ming, E.; Lee, J.Y.; Fireman, B.; Markson, L.E. 2004: Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate Journal of Clinical Psychiatry 65(7): 959-965
Crown, W.H. 2000: Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression Acta Psychiatrica Scandinavica. Supplementum 403: 62-66
Bishop, J.R.; Ellingrod, V.L.; Akroush, M.; Moline, J. 2009: The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives Human Psychopharmacology 24(3): 207-215
Ireland, R.R. 2002: Pharmacologic considerations for serotonin reuptake inhibitor use by aviators Aviation Space and Environmental Medicine 73(5): 421-429
Pacher, P.ál.; Kecskeméti, V.ér. 2004: Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants Orvosi Hetilap 145(8): 425-431
Condat, A.; Mouren-Simeoni, M.C. 2000: Selective serotonin reuptake inhibitors and depression in the child and adolescent L'Encephale 26(3): 53-60
Ostroff, R.B.; Nelson, J.C. 1999: Risperidone augmentation of selective serotonin reuptake inhibitors in major depression Journal of Clinical Psychiatry 60(4): 256-259
Joffe, R.T.; Schuller, D.R. 1993: An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression Journal of Clinical Psychiatry 54(7): 269-271
Pacher, P.; Ungvari, Z.; Kecskemeti, V.; Furst, S. 1998: Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants Current Medicinal Chemistry 5(5): 381-390
Wan, G.J.; Crown, W.H.; Berndt, E.R.; Finkelstein, S.N.; Ling, D. 2002: Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety International Journal of Clinical Practice 56(6): 434-439
Tollefson, G.D.; Greist, J.H.; Jefferson, J.W.; Heiligenstein, J.H.; Sayler, M.E.; Tollefson, S.L.; Koback, K. 1994: Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine Journal of Clinical Psychopharmacology 14(6): 385-391
Beauquier, B.; Fahs, H. 1998: Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy. Apropos of 2 cases L'Encephale 24(1): 62-64
Thor, K.B.; Katofiasc, M.A. 1995: Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat Journal of Pharmacology and Experimental Therapeutics 274(2): 1014-1024
Muraki, I. 2001: Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate Hokkaido Journal of Medical Science 76(2): 57-70
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707
Eriksson, E. 1999: Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria International Clinical Psychopharmacology 14(Suppl 2): S27-S33
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Zajecka, J.; Tracy, K.A.; Mitchell, S. 1997: Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review Journal of Clinical Psychiatry 58(7): 291-297